Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	scavenger receptor binding	FPR2 FPR3	4.94e-05	5	45	2	GO:0005124
GeneOntologyMolecularFunction	N-formyl peptide receptor activity	FPR2 FPR3	4.94e-05	5	45	2	GO:0004982
GeneOntologyMolecularFunction	complement receptor activity	FPR2 FPR3	4.44e-04	14	45	2	GO:0004875
GeneOntologyMolecularFunction	RAGE receptor binding	FPR2 FPR3	5.12e-04	15	45	2	GO:0050786
GeneOntologyBiologicalProcess	positive regulation of mRNA splicing, via spliceosome	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	5.81e-10	44	46	6	GO:0048026
GeneOntologyBiologicalProcess	positive regulation of mRNA processing	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	1.14e-09	49	46	6	GO:0050685
GeneOntologyBiologicalProcess	positive regulation of RNA splicing	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	5.42e-09	63	46	6	GO:0033120
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	1.39e-08	129	46	7	GO:0048024
GeneOntologyBiologicalProcess	regulation of mRNA processing	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	5.64e-08	158	46	7	GO:0050684
GeneOntologyBiologicalProcess	regulation of RNA splicing	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	3.56e-07	207	46	7	GO:0043484
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	1.34e-05	358	46	7	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	1.34e-05	358	46	7	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	1.44e-05	362	46	7	GO:0000375
GeneOntologyBiologicalProcess	positive regulation of mRNA metabolic process	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	2.27e-05	259	46	6	GO:1903313
GeneOntologyBiologicalProcess	male gonad development	RBMY1D RBMY1B RBMY1E ADAM29 RBMY1A1	3.85e-05	171	46	5	GO:0008584
GeneOntologyBiologicalProcess	development of primary male sexual characteristics	RBMY1D RBMY1B RBMY1E ADAM29 RBMY1A1	3.95e-05	172	46	5	GO:0046546
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	5.22e-05	443	46	7	GO:1903311
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	PJA2 TREML4 NCR1 KHDRBS1 PTPRS BTNL2 FPR2 FPR3	5.73e-05	615	46	8	GO:0002764
GeneOntologyBiologicalProcess	male sex differentiation	RBMY1D RBMY1B RBMY1E ADAM29 RBMY1A1	7.90e-05	199	46	5	GO:0046661
GeneOntologyBiologicalProcess	RNA splicing	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	1.14e-04	502	46	7	GO:0008380
GeneOntologyBiologicalProcess	mRNA processing	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1 RBMY1C RBMY1F	2.03e-04	551	46	7	GO:0006397
GeneOntologyBiologicalProcess	immune response-activating signaling pathway	PJA2 TREML4 KHDRBS1 PTPRS BTNL2 FPR2 FPR3	2.07e-04	553	46	7	GO:0002757
GeneOntologyBiologicalProcess	positive regulation of Notch signaling pathway	TSPAN14 TSPAN5 JAG1	2.25e-04	53	46	3	GO:0045747
GeneOntologyBiologicalProcess	positive regulation of gene expression	RBMY1D RBMY1B RBMY1E CHI3L1 KHDRBS1 F2R BTNL2 RBMY1A1 JAG1 RBMY1C RBMY1F	2.63e-04	1446	46	11	GO:0010628
GeneOntologyBiologicalProcess	activation of immune response	PJA2 TREML4 KHDRBS1 PTPRS BTNL2 FPR2 FPR3	4.26e-04	623	46	7	GO:0002253
GeneOntologyBiologicalProcess	gonad development	RBMY1D RBMY1B RBMY1E ADAM29 RBMY1A1	4.68e-04	292	46	5	GO:0008406
GeneOntologyBiologicalProcess	regulation of toll-like receptor 9 signaling pathway	TREML4 PTPRS	5.02e-04	15	46	2	GO:0034163
GeneOntologyBiologicalProcess	development of primary sexual characteristics	RBMY1D RBMY1B RBMY1E ADAM29 RBMY1A1	5.06e-04	297	46	5	GO:0045137
GeneOntologyBiologicalProcess	complement receptor mediated signaling pathway	FPR2 FPR3	5.72e-04	16	46	2	GO:0002430
GeneOntologyBiologicalProcess	collagen fibril organization	COLGALT1 ACAN TLL1	6.51e-04	76	46	3	GO:0030199
GeneOntologyBiologicalProcess	memory	LGMN PJA2 ACSS2 JPH3	7.31e-04	183	46	4	GO:0007613
GeneOntologyBiologicalProcess	hematopoietic progenitor cell differentiation	RBMY1D RBMY1B RBMY1E RBMY1A1	9.63e-04	197	46	4	GO:0002244
GeneOntologyCellularComponent	spliceosomal complex	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	7.34e-06	215	46	6	GO:0005681
GeneOntologyCellularComponent	male germ cell nucleus	RBMY1D RBMY1B RBMY1E RBMY1A1	3.82e-05	86	46	4	GO:0001673
GeneOntologyCellularComponent	germ cell nucleus	RBMY1D RBMY1B RBMY1E RBMY1A1	1.11e-04	113	46	4	GO:0043073
GeneOntologyCellularComponent	specific granule	TSPAN14 ATP8B4 CHI3L1 FPR2	4.20e-04	160	46	4	GO:0042581
GeneOntologyCellularComponent	tertiary granule membrane	TSPAN14 ATP8B4 FPR2	5.57e-04	73	46	3	GO:0070821
GeneOntologyCellularComponent	specific granule membrane	TSPAN14 ATP8B4 FPR2	1.06e-03	91	46	3	GO:0035579
MousePheno	abnormal vomeronasal sensory neuron physiology	FPR2 FPR3	5.72e-05	5	34	2	MP:0011678
MousePheno	abnormal vomeronasal organ physiology	FPR2 FPR3	5.72e-05	5	34	2	MP:0013596
Domain	RBM1CTR	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	2.50e-12	8	42	5	PF08081
Domain	RBM1CTR	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	2.50e-12	8	42	5	IPR012604
Domain	Formyl_pep_2/3_rcpt	FPR2 FPR3	4.94e-06	2	42	2	IPR027347
Domain	RRM_1	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	9.93e-05	208	42	5	PF00076
Domain	RRM	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	1.21e-04	217	42	5	SM00360
Domain	RRM_dom	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	1.50e-04	227	42	5	IPR000504
Domain	RRM	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	1.59e-04	230	42	5	PS50102
Domain	Formyl_rcpt-rel	FPR2 FPR3	2.20e-04	10	42	2	IPR000826
Domain	Nucleotide-bd_a/b_plait	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	2.71e-04	258	42	5	IPR012677
Domain	MetalloPept_cat_dom	ADAMTS17 ADAM29 TLL1	7.99e-04	81	42	3	IPR024079
Domain	-	ADAMTS17 ADAM29 TLL1	7.99e-04	81	42	3	3.40.390.10
Domain	Tetraspanin_CS	TSPAN14 TSPAN5	1.01e-03	21	42	2	IPR018503
Domain	ZINC_PROTEASE	ADAMTS17 ADAM29 TLL1	1.39e-03	98	42	3	PS00142
Domain	TM4_1	TSPAN14 TSPAN5	1.55e-03	26	42	2	PS00421
Domain	ADAM_Cys-rich	ADAMTS17 ADAM29	1.67e-03	27	42	2	IPR006586
Domain	ACR	ADAMTS17 ADAM29	1.67e-03	27	42	2	SM00608
Domain	-	RBMY1D RBMY1B RBMY1E RBMY1F	2.15e-03	244	42	4	3.30.70.330
Domain	Tetraspanin	TSPAN14 TSPAN5	2.35e-03	32	42	2	IPR000301
Domain	Tetraspanin_EC2	TSPAN14 TSPAN5	2.35e-03	32	42	2	IPR008952
Domain	IG	TREML4 NCR1 DSCAM PTPRS BTNL2	2.43e-03	421	42	5	SM00409
Domain	Ig_sub	TREML4 NCR1 DSCAM PTPRS BTNL2	2.43e-03	421	42	5	IPR003599
Domain	Tetraspannin	TSPAN14 TSPAN5	2.49e-03	33	42	2	PF00335
Domain	Tetraspanin/Peripherin	TSPAN14 TSPAN5	2.49e-03	33	42	2	IPR018499
Domain	EGF_1	ADAM29 ITGB1 TLL1 JAG1	2.53e-03	255	42	4	PS00022
Domain	EGF-like_CS	ADAM29 ITGB1 TLL1 JAG1	2.75e-03	261	42	4	IPR013032
Domain	Peptidase_M12B_N	ADAMTS17 ADAM29	3.47e-03	39	42	2	IPR002870
Domain	Pep_M12B_propep	ADAMTS17 ADAM29	3.47e-03	39	42	2	PF01562
Domain	DISINTEGRIN_1	ADAMTS17 ADAM29	3.65e-03	40	42	2	PS00427
Domain	ADAM_MEPRO	ADAMTS17 ADAM29	3.65e-03	40	42	2	PS50215
Domain	DISINTEGRIN_2	ADAMTS17 ADAM29	3.65e-03	40	42	2	PS50214
Domain	Reprolysin	ADAMTS17 ADAM29	3.65e-03	40	42	2	PF01421
Domain	Peptidase_M12B	ADAMTS17 ADAM29	3.65e-03	40	42	2	IPR001590
Domain	Disintegrin_dom	ADAMTS17 ADAM29	3.83e-03	41	42	2	IPR001762
Domain	IG_LIKE	TREML4 NCR1 DSCAM PTPRS BTNL2	4.69e-03	491	42	5	PS50835
Domain	Ig-like_dom	TREML4 NCR1 DSCAM PTPRS BTNL2	5.20e-03	503	42	5	IPR007110
Domain	EGF_extracell	ITGB1 JAG1	8.05e-03	60	42	2	IPR013111
Domain	EGF_2	ITGB1 JAG1	8.05e-03	60	42	2	PF07974
Domain	Ig_V-set	TREML4 DSCAM BTNL2	1.01e-02	199	42	3	IPR013106
Domain	IGv	DSCAM BTNL2	1.23e-02	75	42	2	SM00406
Pathway	PID_UPA_UPAR_PATHWAY	ITGB1 FPR2 FPR3	1.93e-04	42	38	3	M174
Pathway	REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS	FPR2 FPR3	1.96e-04	8	38	2	M27370
Pathway	REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS	FPR2 FPR3	1.96e-04	8	38	2	MM15110
Pubmed	A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	2.67e-17	7	46	6	8269511
Pubmed	Structure and organization of the RBMY genes on the human Y chromosome: transposition and amplification of an ancestral autosomal hnRNPG gene.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	3.50e-15	12	46	6	9598316
Pubmed	RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	1.94e-14	6	46	5	15184870
Pubmed	Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	6.78e-14	7	46	5	8875892
Pubmed	RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing.	RBMY1B KHDRBS1 RBMY1A1 RBMY1C RBMY1F	4.13e-12	13	46	5	10749975
Pubmed	An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.34e-11	5	46	4	8817321
Pubmed	Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-{beta}.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.34e-11	5	46	4	20016065
Pubmed	The role of human and mouse Y chromosome genes in male infertility.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.34e-11	5	46	4	11097427
Pubmed	Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.34e-11	5	46	4	19737860
Pubmed	The behavior of the X- and Y-chromosomes in the oocyte during meiotic prophase in the B6.Y(TIR)sex-reversed mouse ovary.	RBMY1D RBMY1B RBMY1E RBMY1A1	4.01e-11	6	46	4	18239052
Pubmed	Identification of target messenger RNA substrates for mouse RBMY.	RBMY1D RBMY1B RBMY1E RBMY1A1	4.01e-11	6	46	4	18492746
Pubmed	Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist.	RBMY1D RBMY1B RBMY1E RBMY1A1	4.01e-11	6	46	4	12356914
Pubmed	Mouse homologues of the human AZF candidate gene RBM are expressed in spermatogonia and spermatids, and map to a Y chromosome deletion interval associated with a high incidence of sperm abnormalities.	RBMY1D RBMY1B RBMY1E RBMY1A1	4.01e-11	6	46	4	9499427
Pubmed	Does Rbmy have a role in sperm development in mice?	RBMY1D RBMY1B RBMY1E RBMY1A1	4.01e-11	6	46	4	15051956
Pubmed	RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway.	RBMY1D RBMY1B RBMY1E RBMY1A1	9.34e-11	7	46	4	17001072
Pubmed	The roles of RNA-binding proteins in spermatogenesis and male infertility.	RBMY1D RBMY1B RBMY1E RBMY1A1	9.34e-11	7	46	4	10377282
Pubmed	Y chromosome short arm-Sxr recombination in XSxr/Y males causes deletion of Rbm and XY female sex reversal.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.87e-10	8	46	4	7479793
Pubmed	Mice with Y chromosome deletion and reduced Rbm genes on a heterozygous Dazl1 null background mimic a human azoospermic factor phenotype.	RBMY1D RBMY1B RBMY1E RBMY1A1	5.59e-10	10	46	4	10601091
Pubmed	Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene.	RBMY1D RBMY1B RBMY1E RBMY1A1	5.59e-10	10	46	4	9384609
Pubmed	The role of Dby mRNA in early development of male mouse zygotes.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.32e-09	12	46	4	20543856
Pubmed	GASZ promotes germ cell derivation from embryonic stem cells.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.90e-09	13	46	4	23816659
Pubmed	Absence of mDazl produces a final block on germ cell development at meiosis.	RBMY1D RBMY1B RBMY1E RBMY1A1	2.65e-09	14	46	4	14611631
Pubmed	Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome.	RBMY1D RBMY1B RBMY1E RBMY1A1	3.62e-09	15	46	4	14762062
Pubmed	Loss of maternal Trim28 causes male-predominant early embryonic lethality.	RBMY1D RBMY1B RBMY1E RBMY1A1	6.29e-09	17	46	4	28115466
Pubmed	Sex differences in sex chromosome gene expression in mouse brain.	RBMY1D RBMY1B RBMY1E RBMY1A1	8.08e-09	18	46	4	12023983
Pubmed	MRNIP interacts with sex body chromatin to support meiotic progression, spermatogenesis, and male fertility in mice.	RBMY1D RBMY1B RBMY1E RBMY1A1	3.92e-08	26	46	4	35920200
Pubmed	T-STAR/ETOILE: a novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis.	KHDRBS1 RBMY1A1 RBMY1C	2.58e-07	10	46	3	10332027
Pubmed	Lineage-specific biology revealed by a finished genome assembly of the mouse.	RBMY1D RBMY1B RBMY1E RBMY1A1	8.69e-07	55	46	4	19468303
Pubmed	An abundance of X-linked genes expressed in spermatogonia.	RBMY1D RBMY1B RBMY1E RBMY1A1	1.16e-06	59	46	4	11279525
Pubmed	Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.	FPR2 FPR3	1.71e-06	2	46	2	27317426
Pubmed	Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis.	RBMY1B RBMY1A1	1.71e-06	2	46	2	32473614
Pubmed	Chitinase 3-like-1, Tolloid-like protein 1, and intergenic gene polymorphisms are predictors for hepatocellular carcinoma development after hepatitis C virus eradication by direct-acting antivirals.	CHI3L1 TLL1	1.71e-06	2	46	2	33347699
Pubmed	N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.	FPR2 FPR3	1.71e-06	2	46	2	21543323
Pubmed	Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.	FPR2 FPR3	1.71e-06	2	46	2	17084101
Pubmed	Strain-specific Loss of Formyl Peptide Receptor 3 in the Murine Vomeronasal and Immune Systems.	FPR2 FPR3	1.71e-06	2	46	2	26957543
Pubmed	Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.	FPR2 FPR3	1.71e-06	2	46	2	9151906
Pubmed	Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).	FPR2 FPR3	1.71e-06	2	46	2	12172542
Pubmed	Lipoxin A4 inhibits the production of proinflammatory cytokines induced by β-amyloid in vitro and in vivo.	FPR2 FPR3	1.71e-06	2	46	2	21501589
Pubmed	Nonredundant protective properties of FPR2/ALX in polymicrobial murine sepsis.	FPR2 FPR3	1.71e-06	2	46	2	25512512
Pubmed	A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation.	FPR2 FPR3	1.71e-06	2	46	2	23733341
Pubmed	Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes.	FPR2 FPR3	1.71e-06	2	46	2	8198572
Pubmed	Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3.	FPR2 FPR3	1.71e-06	2	46	2	32617132
Pubmed	N-Formylated humanin activates both formyl peptide receptor-like 1 and 2.	FPR2 FPR3	1.71e-06	2	46	2	15465011
Pubmed	A novel rat lipoxin A4 receptor that is conserved in structure and function.	FPR2 FPR3	1.71e-06	2	46	2	12746227
Pubmed	Defective formyl peptide receptor 2/3 and annexin A1 expressions associated with M2a polarization of blood immune cells in patients with chronic obstructive pulmonary disease.	FPR2 FPR3	5.13e-06	3	46	2	29544524
Pubmed	α2β1 Integrin Is Required for Optimal NK Cell Proliferation during Viral Infection but Not for Acquisition of Effector Functions or NK Cell-Mediated Virus Control.	NCR1 ITGB1	5.13e-06	3	46	2	32015010
Pubmed	The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.	FPR2 FPR3	5.13e-06	3	46	2	19234121
Pubmed	Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene.	FPR2 FPR3	5.13e-06	3	46	2	12218158
Pubmed	Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice.	FPR2 FPR3	5.13e-06	3	46	2	12459252
Pubmed	ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.	FPR2 FPR3	5.13e-06	3	46	2	27207555
Pubmed	Formyl peptide receptor 2 regulates monocyte recruitment to promote intestinal mucosal wound repair.	FPR2 FPR3	5.13e-06	3	46	2	31585047
Pubmed	FoxO4 mediates macrophage M2 polarization by promoting LXA4R expression in an ovalbumin-induced allergic asthma model in mice.	FPR2 FPR3	5.13e-06	3	46	2	37422776
Pubmed	Functional expression of formyl peptide receptor family in human NK cells.	FPR2 FPR3	5.13e-06	3	46	2	19843937
Pubmed	Helicobacter pylori HP(2-20) induces eosinophil activation and accumulation in superficial gastric mucosa and stimulates VEGF-alpha and TGF-beta release by interacting with formyl-peptide receptors.	FPR2 FPR3	5.13e-06	3	46	2	24067461
Pubmed	Formyl peptide receptor 1 up-regulation and formyl peptide receptor 2/3 down-regulation of blood immune cells along with defective lipoxin A4/resolvin D1 production in obstructive sleep apnea patients.	FPR2 FPR3	5.13e-06	3	46	2	31116781
Pubmed	The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration.	LGMN ITGB1	5.13e-06	3	46	2	32080801
Pubmed	Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides.	FPR2 FPR3	5.13e-06	3	46	2	17218541
Pubmed	International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.	FPR2 FPR3	5.13e-06	3	46	2	19498085
Pubmed	Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism.	F2R TFPI2	5.13e-06	3	46	2	14623891
Pubmed	Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.	FPR2 FPR3	5.13e-06	3	46	2	15879124
Pubmed	Formyl peptide receptors from immune and vomeronasal system exhibit distinct agonist properties.	FPR2 FPR3	5.13e-06	3	46	2	22859307
Pubmed	Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4.	FPR2 FPR3	5.13e-06	3	46	2	12410796
Pubmed	Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver.	FPR2 FPR3	5.13e-06	3	46	2	36750693
Pubmed	Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.	FPR2 FPR3	5.13e-06	3	46	2	19342677
Pubmed	Deletion of Annexin A1 in Mice Upregulates the Expression of Its Receptor, Fpr2/3, and Reactivity to the AnxA1 Mimetic Peptide in Platelets.	FPR2 FPR3	5.13e-06	3	46	2	36834844
Pubmed	Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1).	F2R ITGB1	5.13e-06	3	46	2	15247268
Pubmed	Formyl peptide receptors are candidate chemosensory receptors in the vomeronasal organ.	FPR2 FPR3	5.13e-06	3	46	2	19497865
Pubmed	Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production.	FPR2 FPR3	5.13e-06	3	46	2	20435922
Pubmed	Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7.	RBMY1D RBMY1B RBMY1E RBMY1A1	7.81e-06	95	46	4	24029230
Pubmed	Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19.	FPR2 FPR3	1.03e-05	4	46	2	1612600
Pubmed	The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.	FPR2 FPR3	1.03e-05	4	46	2	12470609
Pubmed	Suboptimal activation of protease-activated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen.	F2R ITGB1	1.03e-05	4	46	2	19815553
Pubmed	Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.	FPR2 FPR3	1.03e-05	4	46	2	12560218
Pubmed	An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family.	FPR2 FPR3	1.03e-05	4	46	2	15187149
Pubmed	Lipoxin A4 attenuates hyperoxia‑induced lung epithelial cell injury via the upregulation of heme oxygenase‑1 and inhibition of proinflammatory cytokines.	FPR2 FPR3	1.03e-05	4	46	2	31746387
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	TREML4 NCR1 F2R ITGB1 BTNL2 JAG1 FPR2 FPR3	1.13e-05	824	46	8	20237496
Pubmed	The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes.	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	1.67e-05	241	46	5	12815422
Pubmed	Convergence of FPR-rs3-expressing neurons in the mouse accessory olfactory bulb.	FPR2 FPR3	1.71e-05	5	46	2	23664818
Pubmed	Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine-rich protein 61.	F2R ITGB1	2.56e-05	6	46	2	18687805
Pubmed	The ADAP/SKAP55 signaling module regulates T-cell receptor-mediated integrin activation through plasma membrane targeting of Rap1.	SKAP2 ITGB1	2.56e-05	6	46	2	16980616
Pubmed	Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors.	CHI3L1 ACAN	2.56e-05	6	46	2	20640910
Pubmed	Bacterial MgrB peptide activates chemoreceptor Fpr3 in mouse accessory olfactory system and drives avoidance behaviour.	FPR2 FPR3	3.58e-05	7	46	2	31653840
Pubmed	Tissue factor pathway inhibitor primes monocytes for antiphospholipid antibody-induced thrombosis.	F2R ITGB1	3.58e-05	7	46	2	31434703
Pubmed	Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors.	FPR2 FPR3	3.58e-05	7	46	2	19387439
Pubmed	The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression.	TSPAN14 TSPAN5	3.58e-05	7	46	2	23035126
Pubmed	TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization.	TSPAN14 TSPAN5	4.77e-05	8	46	2	26686862
Pubmed	Role of the Notch ligand Delta1 in embryonic and adult mouse epidermis.	ITGB1 JAG1	4.77e-05	8	46	2	17960184
Pubmed	Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse.	FPR2 FPR3	6.12e-05	9	46	2	9722950
Pubmed	Radial glia regulate Cajal-Retzius cell positioning in the early embryonic cerebral cortex.	ITGB1 ACAN	6.12e-05	9	46	2	21185282
Pubmed	Clustering of vomeronasal receptor genes is required for transcriptional stability but not for choice.	FPR2 FPR3	6.12e-05	9	46	2	36383665
Pubmed	TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals.	TSPAN14 TSPAN5	7.65e-05	10	46	2	23091066
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	RBMY1D RBMY1B RBMY1E KHDRBS1 RBMY1A1	9.41e-05	347	46	5	16033648
Pubmed	Chemosensory Cell-Derived Acetylcholine Drives Tracheal Mucociliary Clearance in Response to Virulence-Associated Formyl Peptides.	FPR2 FPR3	1.12e-04	12	46	2	32294408
Pubmed	A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication.	PTPRS TFPI2 TSPAN5 JAG1	1.99e-04	218	46	4	19460752
Pubmed	Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development.	ADAMTS17 ACAN	2.58e-04	18	46	2	35503090
Pubmed	β1-integrin controls cell fate specification in early lens development.	ITGB1 JAG1	2.88e-04	19	46	2	27596755
Pubmed	RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development.	ACAN JAG1	2.88e-04	19	46	2	20335360
Pubmed	Appearance of new tetraspanin genes during vertebrate evolution.	TSPAN14 TSPAN5	3.20e-04	20	46	2	18291621
Pubmed	Pax9 and Jagged1 act downstream of Gli3 in vertebrate limb development.	ACAN JAG1	3.20e-04	20	46	2	16169709
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	HAUS8 PJA2 C2CD3	3.30e-04	101	46	3	24613305
Interaction	RBMY1E interactions	RBMY1E RBMY1F	2.66e-05	4	43	2	int:RBMY1E
Interaction	RBMY1J interactions	RBMY1E RBMY1A1 RBMY1F	3.18e-05	29	43	3	int:RBMY1J
Interaction	APBB1 interactions	RAB9A KHDRBS1 TSHZ2 SYDE2 JAG1	5.75e-05	195	43	5	int:APBB1
Interaction	RBMY1F interactions	RBMY1E RBMY1A1 RBMY1F	6.15e-05	36	43	3	int:RBMY1F
Cytoband	Yq11.223	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	3.93e-08	93	46	5	Yq11.223
Cytoband	Ensembl 112 genes in cytogenetic band chrYq11	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1F	1.51e-05	311	46	5	chrYq11
Cytoband	19q13.3-q13.4	FPR2 FPR3	7.61e-05	13	46	2	19q13.3-q13.4
Cytoband	15q24	ADAMTS17 ARIH1	2.04e-04	21	46	2	15q24
Cytoband	19p13.11	HAUS8 COLGALT1	2.47e-03	73	46	2	19p13.11
GeneFamily	RNA binding motif containing	RBMY1D RBMY1B RBMY1E RBMY1A1 RBMY1C RBMY1F	6.85e-06	213	40	6	725
GeneFamily	Formyl peptide receptors	FPR2 FPR3	1.43e-05	3	40	2	198
GeneFamily	CD molecules\|Tetraspanins	TSPAN14 TSPAN5	2.41e-03	33	40	2	768
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	C2CD3 SYDE2	2.87e-03	36	40	2	823
GeneFamily	Adenosine receptors\|V-set domain containing	TREML4 ACAN BTNL2	5.57e-03	163	40	3	590
Coexpression	CHEN_ETV5_TARGETS_TESTIS	RBMY1D RBMY1B RBMY1E RBMY1A1	2.73e-07	33	44	4	MM701
Coexpression	ZHENG_IL22_SIGNALING_DN	RBMY1D RBMY1B RBMY1E RBMY1A1	9.78e-07	45	44	4	MM763
Coexpression	HALLMARK_CHOLESTEROL_HOMEOSTASIS	LGMN ACSS2 CHKA JAG1	7.29e-06	74	44	4	M5892
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	LGMN TSPAN14 CHKA TSHZ2 PTPRS	1.60e-05	189	44	5	M3112
Coexpression	HUANG_FOXA2_TARGETS_UP	F2R TFPI2 JAG1	6.80e-05	47	44	3	M15326
Coexpression	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	LGMN CHI3L1 MAOA FPR3	1.17e-04	150	44	4	M7388
Coexpression	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	CHI3L1 CHKA ACAN JAG1	1.26e-04	153	44	4	M1139
Coexpression	DARWICHE_PAPILLOMA_RISK_HIGH_UP	CHI3L1 CHKA ACAN JAG1	1.30e-04	154	44	4	M1135
Coexpression	WANG_SMARCE1_TARGETS_UP	CHI3L1 F2R TSHZ2 ACAN JAG1	1.30e-04	294	44	5	M1804
Coexpression	KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	RAB9A ITGB1 TFPI2	1.41e-04	60	44	3	M1816
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	ATP8B4 NCR1 DSCAM F2R	1.54e-04	161	44	4	M9446
Coexpression	SASAKI_TARGETS_OF_TP73_AND_TP63	ITGB1 JAG1	1.80e-04	12	44	2	M17374
Coexpression	DARWICHE_PAPILLOMA_RISK_LOW_UP	CHI3L1 CHKA ACAN JAG1	1.81e-04	168	44	4	M1133
Coexpression	GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN	ATP8B4 CHI3L1 IMPA2 JAG1	1.81e-04	168	44	4	M5662
Coexpression	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	PJA2 ATP8B4 COLGALT1 MAOA F2R PTPRS	1.90e-04	506	44	6	M253
Coexpression	DARWICHE_PAPILLOMA_RISK_HIGH_UP	CHI3L1 CHKA ACAN JAG1	2.12e-04	175	44	4	MM499
Coexpression	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	CHI3L1 CHKA ACAN JAG1	2.12e-04	175	44	4	MM501
Coexpression	MURARO_PANCREAS_DUCTAL_CELL	TSPAN14 RAB9A CHI3L1 IMPA2 ACSS2 TSHZ2 ITGB1 TFPI2 JAG1	2.26e-04	1276	44	9	M39173
Coexpression	GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN	ATP8B4 COLGALT1 NCR1 ITGB1	2.89e-04	190	44	4	M4662
Coexpression	SHEPARD_CRASH_AND_BURN_MUTANT_DN	LGMN PPP1R3G KHDRBS1 JAG1	2.95e-04	191	44	4	M2148
Coexpression	DARWICHE_PAPILLOMA_RISK_LOW_UP	CHI3L1 CHKA ACAN JAG1	3.01e-04	192	44	4	MM497
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN	C2CD3 ATP8B4 ARIH1 NCR1	3.32e-04	197	44	4	M4421
Coexpression	GSE22886_NAIVE_TCELL_VS_NKCELL_DN	C2CD3 ATP8B4 ARIH1 NCR1	3.39e-04	198	44	4	M4415
Coexpression	GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP	USP43 TSPAN14 ATP8B4 F2R	3.45e-04	199	44	4	M9480
Coexpression	GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN	IMPA2 CHKA SKAP2 FPR3	3.45e-04	199	44	4	M8712
Coexpression	GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN	LGMN ATP8B4 TREML4 F2R	3.45e-04	199	44	4	M3070
Coexpression	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN	USP43 NCR1 PPP1R3G NOTUM	3.45e-04	199	44	4	M4328
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN	HAUS8 CHKA DSCAM FPR2	3.52e-04	200	44	4	M9318
Coexpression	GSE15767_MED_VS_SCS_MAC_LN_UP	TREML4 SKAP2 BTNL2 FPR2	3.52e-04	200	44	4	M3584
Coexpression	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN	TSPAN14 ATP8B4 IMPA2 TLL1	3.52e-04	200	44	4	M8651
Coexpression	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP	C2CD3 CHI3L1 MAOA TFPI2	3.52e-04	200	44	4	M9909
Coexpression	GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN	CHKA DSCAM ITGB1 PTPRS	3.52e-04	200	44	4	M7177
Coexpression	GSE17721_POLYIC_VS_CPG_4H_BMDC_UP	PJA2 TSPAN14 RAB9A COLGALT1	3.52e-04	200	44	4	M3940
Coexpression	GSE22886_DC_VS_MONOCYTE_UP	CHKA MAOA JAG1 FPR3	3.52e-04	200	44	4	M4471
Coexpression	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	FPR2 FPR3	4.62e-04	19	44	2	MM773
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	HAUS8 TREML4 CHKA DSCAM SKAP2 JAG1	1.00e-04	383	42	6	GSM605826_500
CoexpressionAtlas	NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3	ATP8B4 NCR1 ACSS2 F2R ITGB1 TSPAN5	1.03e-04	385	42	6	GSM538285_500
CoexpressionAtlas	Myeloid Cells, DC.4+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	HAUS8 TREML4 CHKA DSCAM SKAP2 JAG1	1.27e-04	400	42	6	GSM538242_500
CoexpressionAtlas	NK cells, NK.MCMV7.Sp, CD3-,NK1.1+, Spleen, avg-3	ATP8B4 NCR1 ACSS2 F2R ITGB1 TSPAN5	1.47e-04	411	42	6	GSM538312_500
CoexpressionAtlas	NK cells, NK.H+.MCMV7.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3	ATP8B4 NCR1 ACSS2 F2R ITGB1 TSPAN5	1.51e-04	413	42	6	GSM538303_500
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-\|bone_marrow / Manually curated celltypes from each tissue	ADAMTS17 USP43 ATP8B4 NCR1 CHKA JAG1	3.18e-08	194	43	6	5c58a2d1dd3c8ff77ce44d473239685e6b020909
ToppCell	COPD-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	ADAMTS17 ATP8B4 NCR1 CHKA JAG1	6.78e-07	173	43	5	4a0043b29f8ede5a74bdb38cbf2c70e12b25e130
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSPAN14 TSHZ2 ITGB1 TLL1 JAG1	7.18e-07	175	43	5	2e54961846c65b185d9bd6e305dd81205579d890
ToppCell	IPF-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	ADAMTS17 ATP8B4 NCR1 CHKA JAG1	7.18e-07	175	43	5	b6d1e40d9339426d778481fd67ab7cbc0f6cb5b2
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSPAN14 TSHZ2 ITGB1 TLL1 JAG1	7.18e-07	175	43	5	efa6a05f7417d46141b6e635f258c126b7a03aa1
ToppCell	10x5'-Liver-Lymphocytic_NK-NK_CD56bright_CD16-\|Liver / Manually curated celltypes from each tissue	ADAMTS17 ATP8B4 NCR1 CHKA JAG1	1.25e-06	196	43	5	4ad73515af265432235b698fceb0ba370ced3e52
ToppCell	ILEUM-non-inflamed-(6)_ILC\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ATP8B4 NCR1 CHKA SKAP2 ITGB1	1.29e-06	197	43	5	76a233eb9611d24b9bb9f4359c26606332a3c29e
ToppCell	mLN-(0)_NK_cell-(00)_NK\|mLN / shred on region, Cell_type, and subtype	ADAMTS17 ATP8B4 NCR1 CHKA ITGB1	1.35e-06	199	43	5	59d8e4f57580c7273308c32e5308fc1d704b1f6d
ToppCell	mLN-NK_cell-NK\|mLN / Region, Cell class and subclass	ADAMTS17 ATP8B4 NCR1 CHKA ITGB1	1.35e-06	199	43	5	cc9836b8d18edabe8849a3e948b84d954ef68c48
ToppCell	mLN-NK_cell\|mLN / Region, Cell class and subclass	ADAMTS17 ATP8B4 NCR1 CHKA ITGB1	1.35e-06	199	43	5	dcc1d9a3f6f0e64f111d18386bfe5b154e9d5bbe
ToppCell	mLN-(0)_NK_cell\|mLN / shred on region, Cell_type, and subtype	ADAMTS17 ATP8B4 NCR1 CHKA ITGB1	1.35e-06	199	43	5	05f5ae4c049f242131a7f59bcce4b18ed52f11be
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 TREML4 JAG1 FPR2	1.54e-05	156	43	4	2ba838bc864c2c1767bcab7bb4d790af96b91387
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN CHI3L1 SKAP2 FPR2	1.58e-05	157	43	4	c3451b33780499fd62672e7cd71c7e8cb6ccc2c5
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN CHI3L1 SKAP2 FPR2	1.58e-05	157	43	4	92cd58b62e46b93f90e05657fd201404ccae6ddb
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN CHI3L1 SKAP2 FPR2	1.58e-05	157	43	4	042129d1b514dc4ed8a5f45b52d9c73cf4807636
ToppCell	droplet-Limb_Muscle-nan-24m-Myeloid-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8B4 CHI3L1 FPR2 JPH3	1.66e-05	159	43	4	39033d49501a4ecc00af6c256e7a569c903ad332
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS17 CHI3L1 DSCAM FPR2	1.79e-05	162	43	4	9c9a63adb692651ea5a52cc77b02c5ce11d0ccea
ToppCell	droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS17 CHI3L1 DSCAM FPR2	1.79e-05	162	43	4	1d29983b22f963b34e72cfd1eec328d2d7c4932f
ToppCell	droplet-Spleen-nan-21m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHI3L1 DSCAM SKAP2 FPR2	1.93e-05	165	43	4	fbd84f211ad645c91b9f45a0815391606f3206ac
ToppCell	droplet-Spleen-nan-21m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHI3L1 DSCAM SKAP2 FPR2	1.93e-05	165	43	4	6fbdfacb49e627712ac999d40ae22dcb390edd3e
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	ADAMTS17 ATP8B4 NCR1 JAG1	1.97e-05	166	43	4	ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCell	facs-Liver-Non-hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LGMN TREML4 TLL1 FPR2	2.07e-05	168	43	4	95416f352801ce42cc317565e7dfb00478c593e1
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-NK_T_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS17 ATP8B4 NCR1 NOTUM	2.07e-05	168	43	4	b4b73f3fc9f4c3d87ca0a63ff8b2842141ccd0e6
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS17 ATP8B4 NCR1 TSPAN5	2.11e-05	169	43	4	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSPAN14 TSHZ2 ITGB1 JAG1	2.16e-05	170	43	4	af8b56555cbd5a1016ab9ec2ce88225c58c89648
ToppCell	T_cells-CD56_bright_CD16-_NK_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	USP43 ATP8B4 NCR1 CHKA	2.27e-05	172	43	4	980e8b9e1ceeb0dec9eb9ef95c139e5ffe99b6e4
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSPAN14 TSHZ2 ITGB1 JAG1	2.27e-05	172	43	4	9a1743abcd5fbd38253ea84d88ad716cfb71de36
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_T_(gd)\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	USP43 ATP8B4 NCR1 PTPRS	2.32e-05	173	43	4	62f2f42f54c9c6941bf888956be40230f92c883e
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	USP43 LGMN ATP8B4 FPR3	2.42e-05	175	43	4	c58a1f02d1e559d3638fe1500e960e82a8a7187b
ToppCell	COPD-Lymphoid-ILC_A\|COPD / Disease state, Lineage and Cell class	ADAMTS17 ATP8B4 NCR1 JAG1	2.48e-05	176	43	4	484452cb38fe4604f0910a068361ed461b5b0c21
ToppCell	Control-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	LGMN ATP8B4 SYDE2 FPR3	2.53e-05	177	43	4	470f54fe2b21c7350ea471e02039461a3808f700
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LGMN ATP8B4 COLGALT1 FPR3	2.59e-05	178	43	4	24e8c62060455159235985f456af0c5023a7f3f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	LGMN ATP8B4 COLGALT1 FPR3	2.59e-05	178	43	4	4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084
ToppCell	COVID-19-Heart-Lymph_EC\|Heart / Disease (COVID-19 only), tissue and cell type	SKAP2 TSHZ2 TSPAN5 TLL1	2.65e-05	179	43	4	411620201a860716a8773b92f50f7b94ef34a586
ToppCell	3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TSHZ2 PTPRS TSPAN5 TLL1	2.65e-05	179	43	4	ec1d7017da325647b629de703135a404bbdc627d
ToppCell	3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-NK_T_cell\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ATP8B4 NCR1 NOTUM TSPAN5	2.77e-05	181	43	4	ee1c5af8ed75dd8a0ed3152ba5b9a42d2a8c2ae4
ToppCell	IPF-Lymphoid-ILC_A\|World / Disease state, Lineage and Cell class	ADAMTS17 ATP8B4 NCR1 TSPAN5	2.83e-05	182	43	4	f91bb45baaec76cb3bb26eedbcf0709b2492e93f
ToppCell	IPF-Lymphoid-ILC_A\|IPF / Disease state, Lineage and Cell class	ADAMTS17 ATP8B4 NCR1 TSPAN5	2.89e-05	183	43	4	49bfeaae13eb236f61a5486ee75c39789936bb8a
ToppCell	Control-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	ADAMTS17 ATP8B4 CHKA JAG1	3.01e-05	185	43	4	520795866d44def5be3910ce8e728045c716a24d
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-NK_T_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS17 ATP8B4 NCR1 NOTUM	3.34e-05	190	43	4	f7f617e55fdad3a1607060628be3d2d2b948039c
ToppCell	ILEUM-non-inflamed-(6)_ILC3\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ATP8B4 CHKA SKAP2 ITGB1	3.41e-05	191	43	4	6eaf72b41084404bee0db04e4605db745a74995f
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	LGMN ATP8B4 SKAP2 FPR3	3.63e-05	194	43	4	f09675cd472200363c458952f00d2e41990800ee
ToppCell	ILEUM-inflamed-(3)_moDC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	LGMN ATP8B4 CHKA FPR3	3.63e-05	194	43	4	c9d2acab0bbcfa9a9113cf3b9f8147403f0beb43
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PJA2 PTPRS TSPAN5 JAG1	3.63e-05	194	43	4	8b81f039f5b25d35a4d5a41b27d4d9360ba22f15
ToppCell	ILEUM-inflamed-(6)_ILC\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ATP8B4 NCR1 CHKA ITGB1	3.63e-05	194	43	4	4d51d49366c34ff1241770b4acc0167a43b3155a
ToppCell	distal-1-Hematologic-IGSF21+_Dendritic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LGMN ATP8B4 CHKA FPR3	3.63e-05	194	43	4	f30c866e5f41ee79bdc6b6e08af962d62b199835
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-\|lymph-node_spleen / Manually curated celltypes from each tissue	ADAMTS17 ATP8B4 NCR1 JAG1	3.63e-05	194	43	4	8a596f25f6bfa5baaa2f52d80ad92f2925713398
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHI3L1 F2R TSHZ2 TSPAN5	3.63e-05	194	43	4	43eb677a76634bb9a48a40e0d607c4936ae64bcc
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHI3L1 F2R TSHZ2 TSPAN5	3.63e-05	194	43	4	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	Mild-NK\|Mild / Disease group and Cell class	ATP8B4 NCR1 SKAP2 JAG1	3.70e-05	195	43	4	be88a7507cd6a0a9dfe424312d9365039eef7b74
ToppCell	(0)_NK/T_cells-(0)_NK_T_CD8_Cytotoxic\|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ATP8B4 NCR1 CHKA SKAP2	3.70e-05	195	43	4	13717c6e42882162445bc1b1445d66efcb68e19d
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHI3L1 TSHZ2 PTPRS TFPI2	3.70e-05	195	43	4	fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCell	(0)_NK_cells-(0)_NK_CD160pos\|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ADAMTS17 ATP8B4 CHKA SKAP2	3.70e-05	195	43	4	6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|GI_small-bowel / Manually curated celltypes from each tissue	ADAMTS17 ATP8B4 NCR1 CHKA	3.77e-05	196	43	4	5755ca4abcae3717894bbf7cbd49bca0a3a03067
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHI3L1 F2R TSHZ2 TSPAN5	3.77e-05	196	43	4	023477a499a2c190f363cfdbc9d9c646733a6541
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo\|GI_small-bowel / Manually curated celltypes from each tissue	ADAMTS17 ATP8B4 NCR1 ITGB1	3.77e-05	196	43	4	a54ec174461944229c98a0b48b4822a556191ccb
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CHI3L1 F2R TSHZ2 TSPAN5	3.77e-05	196	43	4	3cb74f1a333a82cac2b459f2f1517e2acf22b5fd
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS17 ATP8B4 NCR1 TSPAN5	3.77e-05	196	43	4	bbdc92ec2e95ed7d782df0c72d94f9a9d9439bf0
ToppCell	Control-Myeloid-DC2\|Control / Condition, Lineage and Cell class	LGMN ATP8B4 IMPA2 FPR3	3.77e-05	196	43	4	0ccc26c2811e4c8631e0abd8555b167ac1e7a982
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|GI_small-bowel / Manually curated celltypes from each tissue	ADAMTS17 ATP8B4 NCR1 ITGB1	3.77e-05	196	43	4	84cab9390794fe50203834b745722bf11c208ebd
ToppCell	5'-Adult-Appendix\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHI3L1 TSHZ2 PTPRS TFPI2	3.77e-05	196	43	4	a579211ef14f348d0c5a290553150222dfbf1515
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo\|GI_small-bowel / Manually curated celltypes from each tissue	ADAMTS17 ATP8B4 NCR1 CHKA	3.77e-05	196	43	4	181f3c1af565355b29f20ca6074147c313ca3477
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHI3L1 F2R TSHZ2 TSPAN5	3.77e-05	196	43	4	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHI3L1 TSHZ2 PTPRS TFPI2	3.85e-05	197	43	4	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	distal-Hematologic-Interstitial_Macrophage-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LGMN ATP8B4 COLGALT1 FPR3	3.85e-05	197	43	4	3b859c3bbb71858b97ce670bd507e67c377b88eb
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ATP8B4 CHI3L1 SKAP2 FPR2	3.93e-05	198	43	4	82f6ac18c3a6487f03579b5c247844f1c115c2be
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ATP8B4 CHI3L1 SKAP2 FPR2	3.93e-05	198	43	4	f870e398e996c1f28c8462d87b18f71b20c71011
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	F2R TSHZ2 ITGB1 TFPI2	3.93e-05	198	43	4	75d104eead681f6bf47c4dd24913cc768c9a1717
ToppCell	normal_Lymph_Node-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	USP43 ATP8B4 NCR1 SKAP2	3.93e-05	198	43	4	75e94298bf03d755fef46df685437d0d29fdbca9
ToppCell	(0)_NK_cell\|World / shred on Cell_type and subtype	ADAMTS17 ATP8B4 NCR1 ITGB1	3.93e-05	198	43	4	dd8d5d635df7d4875c7a19f605e1289bc66bcfa6
ToppCell	mLN-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	USP43 ATP8B4 NCR1 CFAP46	4.00e-05	199	43	4	c81a194f8c2f120c6c4d74857912865a3c2fe1e7
ToppCell	COPD-Myeloid-Macrophage\|Myeloid / Disease state, Lineage and Cell class	LGMN CHI3L1 CHKA FPR3	4.00e-05	199	43	4	1cf1b2d6debf9e3389f1829dcaa2857e9533a080
ToppCell	wk_20-22-Hematologic-Myeloid-SPP1+_Mac\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LGMN ATP8B4 COLGALT1 FPR3	4.00e-05	199	43	4	7c19f1b1f4369edd035ca9cdcf4e653771fc4648
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LGMN ATP8B4 COLGALT1 FPR3	4.00e-05	199	43	4	e1066e638af83ba5e89c7cabb8ad00b6bcdee5f4
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LGMN ATP8B4 COLGALT1 FPR3	4.00e-05	199	43	4	9545ac59c8d75f5747dff86cb511a149dc103b31
ToppCell	Bronchus_Control_(B.)-Immune-TX-MoAM-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	LGMN ATP8B4 COLGALT1 FPR3	4.00e-05	199	43	4	fb63885273d906a85fef178d859d20a311eb8a72
ToppCell	mLN-ILC-ILC\|mLN / Region, Cell class and subclass	ATP8B4 CHKA ITGB1 JAG1	4.00e-05	199	43	4	ab09a06cdea2597e9fe4b4b304655e9de4d433f6
ToppCell	mLN-ILC\|mLN / Region, Cell class and subclass	ATP8B4 CHKA ITGB1 JAG1	4.00e-05	199	43	4	d6c299312c747fb1b7c53644c53efc03a5fffe85
ToppCell	mLN-(3)_ILC\|mLN / shred on region, Cell_type, and subtype	ATP8B4 CHKA ITGB1 JAG1	4.00e-05	199	43	4	00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LGMN ATP8B4 COLGALT1 FPR3	4.00e-05	199	43	4	ca0f6526ba0dcf8789dd3b583291519626427f2f
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	F2R TSHZ2 ITGB1 TFPI2	4.00e-05	199	43	4	3d8c76e3d05acf72a35ca755b51579fc3ae63562
ToppCell	mLN-(3)_ILC-(30)_ILC\|mLN / shred on region, Cell_type, and subtype	ATP8B4 CHKA ITGB1 JAG1	4.00e-05	199	43	4	33ac6d77099076df01299be429f4ba96f2f34cc1
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related-Oligodendrocyte/OPC\|2m / Sample Type, Dataset, Time_group, and Cell type.	F2R ITGB1 PTPRS JAG1	4.08e-05	200	43	4	3c9a2f02294a9fb892b89e856291bd6423ffa0a9
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	LGMN CHI3L1 COLGALT1 FPR3	4.08e-05	200	43	4	d0ffd0d403a335c477c1b72391078b1595d9630c
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS17 ATP8B4 NCR1 TSPAN5	4.08e-05	200	43	4	1db27223e307efca97502fca40ec5e4f8eea512b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-OPC_related\|2m / Sample Type, Dataset, Time_group, and Cell type.	F2R ITGB1 PTPRS JAG1	4.08e-05	200	43	4	8e49e7e9b02d8411e4ffae1f5113a2c18f5bf179
ToppCell	Transverse-(3)_ILC-(30)_ILC\|Transverse / shred on region, Cell_type, and subtype	ATP8B4 NCR1 CHKA ITGB1	4.08e-05	200	43	4	528520dc98775aca6cc7568fedf5906ea55e0bea
ToppCell	Transverse-(3)_ILC\|Transverse / shred on region, Cell_type, and subtype	ATP8B4 NCR1 CHKA ITGB1	4.08e-05	200	43	4	c1ad7cb012e1c8911e417f7d64ca662c4f5010e0
ToppCell	Transverse-ILC\|Transverse / Region, Cell class and subclass	ATP8B4 NCR1 CHKA ITGB1	4.08e-05	200	43	4	eb04d6ad2270d3d9ac3d1fae1bb9bedc6fca38fe
ToppCell	Transverse-ILC-ILC\|Transverse / Region, Cell class and subclass	ATP8B4 NCR1 CHKA ITGB1	4.08e-05	200	43	4	60ec185df2f1989bf8febf75b11c46a576829be3
ToppCell	(3)_ILC\|World / shred on Cell_type and subtype	ATP8B4 CHKA ITGB1 JAG1	4.08e-05	200	43	4	03554b3f323785b1e0b48fa32de0d92065dd798e
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	MAOA SKAP2 TLL1 JAG1	4.08e-05	200	43	4	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	(00)_NK\|World / shred on Cell_type and subtype	ADAMTS17 ATP8B4 NCR1 ITGB1	4.24e-05	202	43	4	da1667a138a1195bd5fc9281495dd10e73066843
ToppCell	(30)_ILC\|World / shred on Cell_type and subtype	ATP8B4 CHKA ITGB1 JAG1	4.41e-05	204	43	4	bd9fbd278c05e396463704d711b60d47699e3c09
ToppCell	367C-Epithelial_cells-Epithelial-B_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ADAMTS17 ATP8B4 CHI3L1	1.13e-04	97	43	3	eab10b1af9cd0ce373cd4d0316e0d7b218630584
ToppCell	367C-Epithelial_cells-Epithelial-B_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ADAMTS17 ATP8B4 CHI3L1	1.13e-04	97	43	3	04f571708f2487b0dbd70ee507de6bf75be5f5d9
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IMPA2 F2R ACAN	2.01e-04	118	43	3	d7dcffc0476a6e471debd83904a6569c6f27a594
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IMPA2 F2R ACAN	2.44e-04	126	43	3	3539a8fdbb52d191f36dce68c38798ad4d2b491a
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IMPA2 F2R ACAN	2.99e-04	135	43	3	54b2aaf8d322e01a3ff6099c2422d68ecccf96b4
ToppCell	Control-NK\|World / Disease group and Cell class	ATP8B4 NCR1 CHKA	3.53e-04	143	43	3	fe08adc9472dfd4242497d6c614d0490713261da
Drug	2-chlorodideoxyadenosine	RBMY1D RBMY1B RBMY1E F2R RBMY1A1	1.94e-08	43	44	5	CID000072194
Drug	hydantoin-5-propionic acid	RBMY1D RBMY1B RBMY1E RBMY1A1	7.09e-08	21	44	4	CID000000782
Drug	AZFd	RBMY1D RBMY1B RBMY1E RBMY1A1	1.05e-07	23	44	4	CID000196489
Drug	thioglycolate	RBMY1D RBMY1B RBMY1E IMPA2 RBMY1A1	1.88e-07	67	44	5	CID000001133
Drug	Vistar	RBMY1D RBMY1B RBMY1E RBMY1A1	6.83e-07	36	44	4	CID000040896
Drug	2-oyl	RBMY1D RBMY1B RBMY1E RBMY1A1 FPR3	1.78e-06	105	44	5	CID000657137
Drug	PKI166	RBMY1D RBMY1B RBMY1E RBMY1A1	2.22e-06	48	44	4	CID006918403
Drug	HgCl	RBMY1D RBMY1B RBMY1E RBMY1A1	2.41e-06	49	44	4	CID000024182
Drug	azafagomine	RBMY1D RBMY1B RBMY1E RBMY1A1	4.45e-06	57	44	4	CID011957435
Drug	SU6668	RBMY1D RBMY1B RBMY1E RBMY1A1	1.01e-05	70	44	4	CID000206042
Drug	oligoadenylate	RBMY1D RBMY1B RBMY1E F2R RBMY1A1	1.28e-05	157	44	5	CID000107918
Drug	p11-13	RBMY1D RBMY1B RBMY1E RBMY1A1	1.33e-05	75	44	4	CID000015759
Drug	t-boc-MLP	FPR2 FPR3	2.18e-05	4	44	2	CID000125627
Drug	5-aza-2'-deoxycytidine	RBMY1D RBMY1B RBMY1E F2R TFPI2 TLL1 RBMY1A1 JAG1	2.65e-05	638	44	8	CID000016886
Drug	cyclooctylamine	FPR2 FPR3	3.64e-05	5	44	2	CID000002903
Drug	bipy	RBMY1D RBMY1B RBMY1E RBMY1A1	3.69e-05	97	44	4	CID000001474
Drug	bacteriochlorin A	FPR2 FPR3	5.45e-05	6	44	2	CID000159279
Drug	L-phosphatidyl-glycerol	FPR2 FPR3	5.45e-05	6	44	2	CID000454706
Drug	dimethylfumarate	FPR2 FPR3	5.45e-05	6	44	2	CID000010262
Drug	carbonyl sulfide	RBMY1D RBMY1B RBMY1E RBMY1A1	7.42e-05	116	44	4	CID000010039
Drug	L-valine methyl ester hydrochloride	FPR2 FPR3	1.01e-04	8	44	2	CID000094285
Drug	Fmlp Ome	FPR2 FPR3	1.01e-04	8	44	2	CID000122066
Drug	AC1L524D	FPR2 FPR3	1.01e-04	8	44	2	CID000196667
Drug	5-fluoro-alpha-methyltryptamine	MAOA F2R	1.01e-04	8	44	2	CID000012834
Drug	3-amino-2-oxazolidinone	MAOA JAG1	1.30e-04	9	44	2	CID000065725
Drug	AC1L252K	FPR2 FPR3	1.30e-04	9	44	2	CID000015061
Drug	PEG-SS	JAG1 FPR2 FPR3	1.31e-04	51	44	3	CID000123663
Drug	baryta	ARIH1 FPR2 FPR3 JPH3	1.37e-04	136	44	4	CID000062392
Drug	safrazine	MAOA F2R	1.63e-04	10	44	2	CID000034041
Drug	ara-AC	RBMY1D RBMY1B RBMY1E TFPI2 RBMY1A1	1.96e-04	279	44	5	CID000001805
Drug	antiflammin-2	FPR2 FPR3	1.99e-04	11	44	2	CID000003612
Disease	temporal arteritis (is_marker_for)	CHI3L1 JAG1	3.94e-05	7	41	2	DOID:13375 (is_marker_for)
Disease	motor function measurement	ADAMTS17 TSHZ2	1.03e-04	11	41	2	EFO_0010749
Disease	Dupuytren Contracture	PJA2 ACAN JAG1	4.59e-04	108	41	3	EFO_0004229
Disease	congenital heart disease (is_implicated_in)	TLL1 JAG1	5.10e-04	24	41	2	DOID:1682 (is_implicated_in)
Disease	stroke	IMPA2 TSPAN5 JPH3	1.06e-03	144	41	3	EFO_0000712
Disease	Endometrioma	IMPA2 MAOA ITGB1	1.46e-03	161	41	3	C0269102
Disease	Endometriosis	IMPA2 MAOA ITGB1	1.46e-03	161	41	3	C0014175
Disease	multiple sclerosis (is_marker_for)	ACAN JAG1	2.13e-03	49	41	2	DOID:2377 (is_marker_for)
Disease	diastolic blood pressure, systolic blood pressure	C2CD3 ATP8B4 SKAP2 ACAN JAG1	2.27e-03	670	41	5	EFO_0006335, EFO_0006336
Disease	Colorectal Carcinoma	ADAM29 NCR1 PTPRS TFPI2 JPH3	2.77e-03	702	41	5	C0009402
Disease	pre-eclampsia (is_marker_for)	CHI3L1 F2R	2.96e-03	58	41	2	DOID:10591 (is_marker_for)
Disease	Crohn's disease	TSPAN14 SKAP2 TSHZ2 BTNL2	3.22e-03	441	41	4	EFO_0000384
Disease	renal agenesis, unilateral	TSHZ2 ACAN	3.27e-03	61	41	2	MONDO_0019636
Disease	SARS-CoV-2 antibody measurement, response to COVID-19 vaccine	COLGALT1 DSCAM	3.38e-03	62	41	2	EFO_0803360, EFO_0803362
Disease	rheumatoid arthritis (is_marker_for)	CHI3L1 ACAN	4.17e-03	69	41	2	DOID:7148 (is_marker_for)
Disease	Liver Cirrhosis, Experimental	LGMN F2R SKAP2 ITGB1 TFPI2	4.21e-03	774	41	5	C0023893
Disease	bipolar disorder, body mass index	TSHZ2 JPH3	4.53e-03	72	41	2	EFO_0004340, MONDO_0004985
Disease	forced expiratory volume	ADAMTS17 ATP8B4 DSCAM SKAP2 ACAN	4.56e-03	789	41	5	EFO_0004314
Disease	schizophrenia (is_implicated_in)	CHI3L1 IMPA2	5.29e-03	78	41	2	DOID:5419 (is_implicated_in)
Disease	Glioblastoma	CHI3L1 JAG1	5.42e-03	79	41	2	C0017636

Protein segments in the cluster

Peptide	Gene	Start	Entry
FSNCSYGDFWEYTVE	ADAM29	366	Q9UKF5
QYWCHFQDGNYCGET	BTNL2	121	Q9UIR0
QWEQALGSCSGFFFY	CFAP46	2466	Q8IYW2
GFFCGFSAQTVYDQW	ATP8B4	891	Q8TF62
GDGCQRDQDGYYWIT	ACSS2	551	Q9NR19
SFCHWQNEEYGGARY	ADAMTS17	306	Q8TE56
DRYGRSWESYSSCGD	RBMY1A1	426	P0DJD3
DRYGRSWESYSSCGD	RBMY1B	426	A6NDE4
DRYGRSWESYSSCGD	RBMY1C	426	P0DJD4
DRYGRSWESYSSCGD	RBMY1D	426	P0C7P1
DRYGRSWESYSSCGD	RBMY1E	426	A6NEQ0
DRYGRSWESYSSCGD	RBMY1F	426	Q15415
WCRDNGDYPYFETSA	RAB9A	141	P51151
VDDCWFYFTYSVNGN	ITGB1	696	P05556
PHGSAWYNCNRYNED	ARIH1	381	Q9Y4X5
NWCEEQYSGGCYTAY	MAOA	396	P21397
GTYRCFGSYNNHAWS	NCR1	186	O76036
NGDTYCTFNFASWGG	FPR2	171	P25090
NGDTYCIFNFAFWGD	FPR3	171	P25089
CYYTSWSQYREGDGS	CHI3L1	26	P36222
WYFNQDSACRESGGA	HAUS8	346	Q9BT25
SGAADAYYQFGLHCW	IMPA2	216	O14732
AYEAGYEQCDAGWLR	ACAN	516	P16112
CDQYWPNRGTETYGF	PTPRS	1501	Q13332
YYFSGSDWQFGSELC	F2R	161	P25116
CSGDVLGENYADWYQ	IGLV3-22	41	A0A075B6J6
GGWYCFNRENCDSRY	NOTUM	126	Q6P988
SGFQFVCGWYNITDF	C2CD3	1736	Q4AC94
YNYRGFDIGNHFCEW	CHKA	336	P35790
DSYEAYGQDDWNGTR	KHDRBS1	406	Q07666
AAYSNFWCGMTSQGY	COLGALT1	196	Q8NBJ5
CYNSGTCVDGDNWYR	JAG1	791	P78504
AEDSGYYSCIANNNW	DSCAM	1351	O60469
NRYAGDWSSCGENYF	SYDE2	1086	Q5VT97
WVCAGLDYDYTFDGN	TLL1	26	O43897
TDYANFYQGLWDCTG	SKAP2	296	O75563
YRCAQGEYWDNNAGA	PPP1R3G	331	B7ZBB8
AYCRNSLDGQWYSYD	USP43	671	Q70EL4
QNDSGFYWCGIYNAS	TREML4	101	Q6UXN2
GYQNGASYTWQFEAC	TSHZ2	361	Q9NRE2
FTQEYWQCCGAFGAD	TSPAN5	146	P62079
DWDLNVYFNCSGASY	TSPAN14	161	Q8NG11
YGGCEGNANNFYTWE	TFPI2	66	P48307
EVDNTFWNGCGDYYQ	PJA2	406	O43164
YEGEWASNRRHGYGC	JPH3	311	Q8WXH2
GSNGWYNYRHQADAC	LGMN	36	Q99538